In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
A fourth medicine, tripeptide (Mounjaro), will be available in March next year. Certain criteria must be met for people to be able to receive a prescription for any of these treatments.